GlassScriptPhysician profile
Paul B Plowman
NPI 1619923463
$3,842.60
in general payments reported to CMS, 2019-2025
12 companies · $58.33 in 2025
The $58.33 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.06 · 2020: $629 · 2021: $3,011 · 2023: $18.01 · 2024: $71.00 · 2025: $58.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,613.00 | 2020-2021 | |
| Axonics, INC. | $37.76 | 2024 | Bulkamid |
| Ethicon US, LLC | $33.95 | 2025 | Ethicon, Vistaseal, Stratafix |
| Vertex Pharmaceuticals Incorporated | $24.38 | 2025 | |
| Allergan, INC. | $24.07 | 2019 | |
| Innovation Technologies INC | $19.21 | 2024 | Irrisept |
| Avanos Medical | $18.12 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.01 | 2023 | |
| Sage Therapeutics, LLC | $15.92 | 2020 | |
| Exeltis, USA INC. | $14.03 | 2024 | Slynd |
| Abbvie INC. | $12.87 | 2019 | |
| Evofem Biosciences, INC. | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Plowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.